Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
| | | | | | |

Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer

In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
| | | | | | |

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.

In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…

A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
| | | | | |

A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors

On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…

A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
| | | | | |

A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence

On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…

NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes
| | | | | | |

NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes

On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…

Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, reduced the incidence of some breast cancer outcomes
| | | | | | |

Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, reduced the incidence of some breast cancer outcomes

In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…